1. Home
  2. INDI vs IRWD Comparison

INDI vs IRWD Comparison

Compare INDI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$3.48

Market Cap

750.1M

Sector

Technology

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.29

Market Cap

658.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
IRWD
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
750.1M
658.5M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
INDI
IRWD
Price
$3.48
$4.29
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$6.25
$7.67
AVG Volume (30 Days)
4.8M
2.1M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
3.95
1400.00
EPS
N/A
0.24
Revenue
$217,394,000.00
$298,276,000.00
Revenue This Year
$25.54
$57.95
Revenue Next Year
$38.45
$4.39
P/E Ratio
N/A
$17.29
Revenue Growth
0.33
8.88
52 Week Low
$2.32
$0.81
52 Week High
$6.05
$5.78

Technical Indicators

Market Signals
Indicator
INDI
IRWD
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
INDI
IRWD

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: